VIM and hepatocellular carcinoma: In our previous study, we have shown that downregulation of vimentin by Sendai F/HN viroplexes caused vimentin siRNA to inhibit the growth of hepatocellular carcinoma in vitro, which suggests again that vimentin is a potential target for gene therapy [7].